Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Reexamination Certificate
2008-04-29
2008-04-29
Kishore, Gollamudi S. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
C424S045000, C424S046000, C424S047000, C424S489000
Reexamination Certificate
active
07364749
ABSTRACT:
Use of an anti-infective and/or anti-inflammatory agent for the preparation of a pharmaceutical composition for the treatment of diseases of external or internal parts of the human or animal body which are susceptible to the administration of such agents.
REFERENCES:
patent: 5942245 (1999-08-01), Katinger et al.
patent: 2006/0116713 (2006-06-01), Sepetka et al.
patent: 1323568 (1992-09-01), None
patent: 2204493 (1994-04-01), None
patent: 2215716 (1997-09-01), None
patent: 2 332 389 (1999-05-01), None
patent: 0 267 050 (1988-05-01), None
patent: 02-204413 (1990-08-01), None
patent: WO 85/00112 (1985-01-01), None
patent: WO 87/07502 (1987-12-01), None
patent: WO 88/01862 (1988-03-01), None
patent: WO 91/16882 (1991-11-01), None
patent: WO 92/13873 (1992-08-01), None
patent: WO 93/24165 (1993-12-01), None
patent: WO 96/19199 (1996-06-01), None
patent: WO 96/22764 (1996-08-01), None
patent: WO 96/35435 (1996-11-01), None
patent: WO 98/05340 (1999-01-01), None
patent: WO00/72822 (2000-12-01), None
Bonowitz et al., 2001, “Comparative therapeutic and toxic effects of different povidone iodine (PVP-I) formulations in a model of oral candidosis based on in vitro reconstituted epithelium,” J. Drug Targeting 9(1):75-83.
Brogmann et al., “Liposomal PVP-iodine eye drops—A new drug delivery system for an approved active ingredient,” p. 52.
Damour et al., 1992, “Cytotoxicity evaluation of antiseptics and antibiotics on cultured human fibroblasts and keratinocytes,” Burns 18(6):479-485.
Ganzer et al., 2001, Arthroskopie 14:31-44.
Ganzer et al., “Efficacy and tolerability of povidone-iodine liposome complex in infected knee joints of rabbits,” p. 262, Abstract P1249.
Gottardi, 1991, “Iodine and iodine compounds,” Disinfection, Sterilization, and Preservation, Fourth Ed., Lea & Febiger, Philadelphia pp. 152-156.
Hauser et al., 2001, “Liposomal PVP-iodine hydrogel improves epithelialization of meshed skin grafts—evaluation of the combined effects of moisture and antisepsis,” The Plastic Surgery Research Council 46thAnnual Meeting Jun. 9-12, Milwaukee, WI Clinical Microbiology and Infection 7(Supp 1):36.346.
Kiss et al., 1994, “Toxic effects of heavy metals on ionic channels,” Pharmacol. Rev. 46(3):245-267.
Mayer et al., 1993, “Povidone-iodine and wound healing: A critical review,” Wounds: A Compendium of Clinical Research and Practice 5(1):14-23.
Moren et al., eds., 1993, Aerosols in Medicine. Principles, Diagnosis, and Therapy pp. 70-83, 117-156.
Reimer et al., 2000, “In vitro and in vivo investigations of an innovative topical drug formulation for infection treatment and wound healing: Povidone iodine liposome hydrogel,” Clinical Microbiology and Infection 6(Supp. 1):134-135, Abstract WeP230.
Reimer et al., 2000, “Povidone-iodine liposome complex,” Hyg. Med. Jahrgang Supp. 1:16.15-17.00.
Reimer et al., 1999, “Povidone-iodine liposome complex—a novel anti-infective for topical treatment,” Clin. Microbiol. Inf. 5(supp 3):136 Abstract P192.
Reimer et al., 1998, “Povidone-iodine liposomes—Development of a novel anti-infective for topical treatment,” J. Hosp. Infect. 40(Supp. A): Abstract P.9.2.7.
Reimer et al., 1997, “Povidone-iodine liposomes—and overview,” Dermatology 195(Suppl. 2):93-99.
Stratford et al., 1983, “Effects of topically applied liposomes on disposition of epinephrine and inulin in the albino rabbit eye,” Int. J. Pharmaceutics 13:263-272.
Wutzler et al., “Comparative testing of liposomal and aqueous formulations of povidone-iodine for their angioirritative potential at the chorioallantoic membrane of ex ovo cultivated chick embryos,” Dermatology 207(1):43-47.
Wutzler et al., 2002, “Virucidal activity and cytotoxicity of the liposomal formulation of povidone-iodine,” Antiviral Res. 54:89-97.
Wutzler et al., 2001, “Virucidal activity and cytotoxicity of a liposomal formulation of povidone-iodine,” 14thInternational Conference on Antiviral Research, Seattle, WA 36.988.
Wutzler et al., 2000, “Virucidal activity and cytotoxicity of a liposomal formulation of povidone-iodine,” 7thWestern Pacific Congress of Chemotherapy & Infectious Diseases, Dec. 11-14, Hong Kong.
Wutzler et al., 2000, “Virucidal and chlamydicidal activities of eye drops with povidone-iodine liposome complex,” Ophthalmic Res. 32:118-125.
Seagrave, 2002, “Introduction to Remodeling and Repair in Respiratory Diseases” Chest the Cardiopulmonary and Critical Care Journal, 122:271S.
Edwards, et al., 1997, “Large Porous Particles for Pulmonary Drug Delivery”, Science 276:1868-1871.
Giannelli, et al., 2003, “Tissue remodeling in Liver disease” Histology Histopathol 18:1267-1274.
Forneff-Lipp, et al., 2002, “List of disinfection procedures tested according to the “Guidelines for Testing Chemical Disinfectants” and found effective by the German Society for the decontamination of hands and hygienic handwash)”.
Xiaonan Cia, 1994, “The Clinical Use and Dosage Form of Iodophors”, Bulletin of the Medical School of Shantou University (2):77-89 (in Chinese and English).
Lineaweaver et al., 1985, Arch Surg 120:257-270.
Kallenberger et al., 1991, Hyg & Med 16:383-395.
Fleischer Wolfgang
Reimer Karen
Euro-Celtique S.A.
Jones Day
Kishore Gollamudi S.
LandOfFree
Preparations for the application of anti-infective and/or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preparations for the application of anti-infective and/or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preparations for the application of anti-infective and/or... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2790095